Hoda Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hoda Ahmed has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Fátima Rivera-Escalera
Department of Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, USA
1 shared publication - John A. Olschowka
Department of Neuroscience, Del Monte Institute for Neuroscience, University of Rochester Medical Center, Rochester, NY 14642, USA
1 shared publication - Jonathan J. Pinney
David H. Smith Center for Vaccine Biology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, USA
1 shared publication - Juilee Thakar
Department of Microbiology and Immunology University of Rochester School of Medicine and Dentistry Rochester New York USA
1 shared publication - Laura D. Owlett
Department of Neuroscience, University of Rochester Medical Center, 601 Elmwood Ave, Box 603, Rochester, NY, 14642, USA
1 shared publication - Michael K. O'BAnion
Department of Neuroscience, Del Monte Institute for Neuroscience, University of Rochester School of Medicine & Dentistry, Rochester, USA
1 shared publication
Latest Publications
- Open Access
- 10 December 2019
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 16 (1) , 1-17
IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia
Background: Neuroinflammation is thought to contribute to the pathogenesis of Alzheimer’s disease (AD), yet numerous studies have demonstrated a beneficial role for neuroinflammation in amyloid plaque clearance. We have previously shown that sustained expression of IL-1β in the hippocampus of APP/PS1 mice decreases amyloid plaque burden independent of recruited CCR2+myeloid cells, suggesting resident microglia as the main phagocytic effectors of IL-1β-induced plaque clearance. To date, however, the mechanisms of IL-1β-induced plaque clearance remain poorly understood.Methods: To determine whether microglia are involved in IL-1β-induced plaque clearance, APP/PS1 mice induced to express mature human IL-1β in the hippocampus via adenoviral transduction were treated with the Aβ fluorescent probe methoxy-X04 (MX04) and microglial internalization of fibrillar Aβ (fAβ) was analyzed by flow cytometry and immunohistochemistry. To assess microglial proliferation, APP/PS1 mice transduced with IL-1β or control were injected intraperitoneally with BrdU and hippocampal tissue was analyzed by flow cytometry. RNAseq analysis was conducted on microglia FACS sorted from the hippocampus of control or IL-1β-treated APP/PS1 mice. These microglia were also sorted based on MX04 labeling (MX04+and MX04−microglia).Results: Resident microglia (CD45loCD11b+) constituted > 70% of the MX04+cells in both Phe- and IL-1β-treated conditions, and < 15% of MX04+cells were recruited myeloid cells (CD45hiCD11b+). However, IL-1β treatment did not augment the percentage of MX04+microglia nor the quantity of fAβ internalized by individual microglia. Instead, IL-1β increased the total number of MX04+microglia in the hippocampus due to IL-1β-induced proliferation. In addition, transcriptomic analyses revealed that IL-1β treatment was associated with large-scale changes in the expression of genes related to immune responses, proliferation, and cytokine signaling.Conclusions: These studies show that IL-1β overexpression early in amyloid pathogenesis induces a change in the microglial gene expression profile and an expansion of microglial cells that facilitates Aβ plaque clearance.
- 10 December 2019
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 16 (1) , 1-17
Open AccessIL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia
Background: Neuroinflammation is thought to contribute to the pathogenesis of Alzheimer’s disease (AD), yet numerous studies have demonstrated a beneficial role for neuroinflammation in amyloid plaque clearance. We have previously shown that sustained expression of IL-1β in the hippocampus of APP/PS1 mice decreases amyloid plaque burden independent of recruited CCR2+myeloid cells, suggesting resident microglia as the main phagocytic effectors of IL-1β-induced plaque clearance. To date, however, the mechanisms of IL-1β-induced plaque clearance remain poorly understood.Methods: To determine whether microglia are involved in IL-1β-induced plaque clearance, APP/PS1 mice induced to express mature human IL-1β in the hippocampus via adenoviral transduction were treated with the Aβ fluorescent probe methoxy-X04 (MX04) and microglial internalization of fibrillar Aβ (fAβ) was analyzed by flow cytometry and immunohistochemistry. To assess microglial proliferation, APP/PS1 mice transduced with IL-1β or control were injected intraperitoneally with BrdU and hippocampal tissue was analyzed by flow cytometry. RNAseq analysis was conducted on microglia FACS sorted from the hippocampus of control or IL-1β-treated APP/PS1 mice. These microglia were also sorted based on MX04 labeling (MX04+and MX04−microglia).Results: Resident microglia (CD45loCD11b+) constituted > 70% of the MX04+cells in both Phe- and IL-1β-treated conditions, and < 15% of MX04+cells were recruited myeloid cells (CD45hiCD11b+). However, IL-1β treatment did not augment the percentage of MX04+microglia nor the quantity of fAβ internalized by individual microglia. Instead, IL-1β increased the total number of MX04+microglia in the hippocampus due to IL-1β-induced proliferation. In addition, transcriptomic analyses revealed that IL-1β treatment was associated with large-scale changes in the expression of genes related to immune responses, proliferation, and cytokine signaling.Conclusions: These studies show that IL-1β overexpression early in amyloid pathogenesis induces a change in the microglial gene expression profile and an expansion of microglial cells that facilitates Aβ plaque clearance.